Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The influential T cell in B-cell neoplasms.

N E Kay, M M Oken, R T Perri

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |December 1, 1983
    PubMed
    Summary

    T-cell abnormalities are common in B-cell malignancies like chronic lymphocytic leukemia and multiple myeloma. These T-cell disorders may influence disease progression and could be therapeutically targeted.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.

    Leukemia·2016
    Same author

    Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

    Leukemia·2016
    Same author

    Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.

    Leukemia & lymphoma·2016
    Same author

    Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study.

    Leukemia & lymphoma·2016
    Same author

    A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

    Leukemia·2015
    Same author

    Axl activates fibroblast growth factor receptor pathway to potentiate survival signals in B-cell chronic lymphocytic leukemia cells.

    Leukemia·2015

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • B-cell malignancies, including chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), have historically focused research on malignant B cells.
    • The role of T lymphocytes in these hematologic cancers has been underappreciated.
    • Emerging evidence indicates significant T-cell dysregulation in CLL and MM patients.

    Purpose of the Study:

    • To review the quantitative and functional T-cell abnormalities in B-cell malignancies.
    • To explore the potential causal link between T-cell defects and disease manifestations in CLL and MM.
    • To discuss the influence of in vivo and in vitro manipulations on T cells and their clinical implications.

    Main Methods:

    • Literature review of studies investigating T-cell populations in B-cell malignancies.
    • Analysis of data on T-cell quantitative and qualitative disorders.
    • Examination of evidence linking T-cell abnormalities to disease progression and therapeutic responses.

    Main Results:

    • Quantitative and qualitative T-cell disorders are prevalent in chronic lymphocytic leukemia and multiple myeloma.
    • Evidence suggests a causal relationship between T-cell dysfunction and specific disease features.
    • T cells in these malignancies demonstrate susceptibility to both in vivo and in vitro modulation.

    Conclusions:

    • T-cell abnormalities are integral to the pathophysiology of B-cell malignancies.
    • Understanding T-cell roles may reveal new therapeutic strategies for CLL and MM.
    • Targeting T-cell dysregulation holds promise for improving clinical outcomes.

    Related Experiment Videos